Patient-reported outcomes worse for patients with rheumatoid arthritis discontinuing TNF inhibitor
For patients with rheumatoid arthritis (RA), patient-reported outcomes (PROs) generally worsen shortly after tumor necrosis factor inhibitor (TNFi) discontinuation, according to a study published in the Journal of Rheumatology.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.